Rocio Ir Macias

38PUBLICATIONS
105CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|May 27, 2026
Parenteral Berberine vs Cisplatin- Loaded Lipid Nanoparticles - Development, Characterisation, Comparative Safety Profiling and Cytotoxicity in Cholangiocarcinoma Cell Models.

|Apr 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

|Dec 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Jesus M Banales, Pedro M Rodrigues, Silvia Affò

|Aug 05, 2025
Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.

Maria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné

|Jul 30, 2025
Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs.

Kevin Delgado-Calvo, Elisa Lozano, Oscar Briz

|Jan 11, 2025
Learning from Other Tumors: Pathways for Progress and Overcoming Challenges in Cholangiocarcinoma.

Giulia Tesini, Chiara Braconi, Lorenza Rimassa

Pageof 7

Frequent Collaborators

20 joint publications

Jose Jg Marin

7 joint publications

Oscar Briz

6 joint publications

Jesper B Andersen

6 joint publications

Guido Carpino